Anika Therapeutics reported 47.54 in PE Price to Earnings for its fiscal quarter ending in June of 2024.





Pe Change Date
Abbott 23.85 1.08 Jun/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Anika Therapeutics 47.54 27.2 Jun/2024
Arrowhead Research 39.19 0 Jun/2026
Halozyme Therapeutics 12.51 1.15 Jun/2026
Integra LifeSciences 10.28 5.21 Jun/2026
Intrexon 7.54 221.44 Dec/2021
J&J 29.43 4.9 Jun/2026
Ligand Pharmaceuticals 84.31 27.81 Jun/2026
Merit Medical Systems 32.36 12.84 Mar/2026
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Sanofi 18.96 7.12 Jun/2026
Smith & Nephew 13.76 3.86 Jun/2026
Stryker 27.46 2.98 Jun/2026
Veracyte 42.77 17.88 Jun/2026
Xencor 29.92 3.22 Sep/2022
Zimmer Biomet Holdings 17.33 8.14 Jun/2026